Lefitolimod (MGN 1703) is a DNA-Based TLR9 Agonist and an Immune Surveillance Reactivator
TLR9 is an important receptor existing in immune system cells (including dendritic cells, macrophages, and other antigen-presenting cells). TLR9 recognizes cellular DNA fragments containing unmethylated cytidine-phosphate-guanosine (CpG DNA) which only…